UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047069
Receipt number R000053698
Scientific Title Validation of repellent material efficacy
Date of disclosure of the study information 2022/03/04
Last modified on 2022/03/04 10:19:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Validation of repellent material efficacy

Acronym

Validation of repellent material efficacy

Scientific Title

Validation of repellent material efficacy

Scientific Title:Acronym

Validation of repellent material efficacy

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Dermatology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm efficacy of repellent material for healthy adult forearm skin.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluation of biting inhibition of Aedes albopictus for human skin


Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Apply test samples for skin area (forearm 40 mg, 20 cm2),following insert forearm into mosquito cage for 10 min. The application is conducted three times per day. The test conducts 12 days.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

59 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy human

Key exclusion criteria

1.People who experienced severe itchiness, swelling, pain by mosquito bites
2.People who experienced long term biting scar remaining.
3.People who experienced severe allergy by ethanol

Target sample size

3


Research contact person

Name of lead principal investigator

1st name Kohei
Middle name
Last name Takeuchi

Organization

Kao Corporation

Division name

Personal health care Lab.

Zip code

131-8501

Address

2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

TEL

+81-3-5630-9461

Email

takeuchi.kouhei@kao.com


Public contact

Name of contact person

1st name Kohei
Middle name
Last name Takeuchi

Organization

Kao Corporation

Division name

Personal health care Lab.

Zip code

131-8501

Address

2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

TEL

+81-3-5630-9461

Homepage URL


Email

takeuchi.kouhei@kao.com


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao corporation

Address

2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

Tel

+81-3-5630-7263

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

花王株式会社(東京都)


Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

3

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 02 Month 01 Day

Date of IRB

2022 Year 02 Month 01 Day

Anticipated trial start date

2022 Year 02 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 03 Month 04 Day

Last modified on

2022 Year 03 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053698